The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABG ACQUISITION CORP I | CL A SHS | G00496102 | 3,208 | 329,400 | SH | SOLE | 329,400 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 15,796 | 2,555,908 | SH | SOLE | 2,555,908 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 31,096 | 46,730 | SH | SOLE | 46,730 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,418 | 7,510 | SH | SOLE | 7,510 | 0 | 0 | ||
AMERISOURCEBERGEN CORP | COM | 03073E105 | 107,108 | 896,680 | SH | SOLE | 896,680 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 2,443 | 70,050 | SH | SOLE | 70,050 | 0 | 0 | ||
ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 4,940 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ATAI LIFE SCIENCES NV | SHS | N0731H103 | 1,109 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 1,282 | 36,580 | SH | SOLE | 36,580 | 0 | 0 | ||
BECTON DICKINSON & CO | COM | 075887109 | 34,548 | 140,540 | SH | SOLE | 140,540 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 55,317 | 3,849,470 | SH | SOLE | 3,849,470 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 132,108 | 466,830 | SH | SOLE | 466,830 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 11,416 | 82,183 | SH | SOLE | 82,183 | 0 | 0 | ||
BIONTECH SE | SPONSORED ADS | 09075V102 | 6,467 | 23,690 | SH | SOLE | 23,690 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 74,096 | 1,707,681 | SH | SOLE | 1,707,681 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 212,075 | 3,584,160 | SH | SOLE | 3,584,160 | 0 | 0 | ||
CANO HEALTH INC | COM CL A | 13781Y103 | 34,930 | 2,754,730 | SH | SOLE | 2,754,730 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 61,228 | 982,630 | SH | SOLE | 982,630 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 42,390 | 211,780 | SH | SOLE | 211,780 | 0 | 0 | ||
CM LIFE SCIENCES III INC | *W EXP 04/30/202 | 125841114 | 214 | 99,998 | SH | SOLE | 99,998 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 14,749 | 173,800 | SH | SOLE | 173,800 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 15,529 | 434,500 | SH | SOLE | 434,500 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 13,123 | 386,190 | SH | SOLE | 386,190 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 1,402 | 42,800 | SH | SOLE | 42,800 | 0 | 0 | ||
ENCOMPASS HEALTH CORP | COM | 29261A100 | 8,975 | 119,600 | SH | SOLE | 119,600 | 0 | 0 | ||
ENVISTA HOLDINGS CORPORATION | COM | 29415F104 | 94,071 | 2,249,972 | SH | SOLE | 2,249,972 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 2,321 | 234,180 | SH | SOLE | 234,180 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 7,613 | 128,450 | SH | SOLE | 128,450 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 3,638 | 164,912 | SH | SOLE | 164,912 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 20,076 | 493,502 | SH | SOLE | 493,502 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 57,612 | 237,360 | SH | SOLE | 237,360 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 140,017 | 1,278,228 | SH | SOLE | 1,278,228 | 0 | 0 | ||
IDEXX LABS INC | COM | 45168D104 | 22,264 | 35,800 | SH | SOLE | 35,800 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 4,290 | 339,951 | SH | SOLE | 339,951 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,134 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 5,159 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 18,364 | 267,000 | SH | Call | SOLE | 267,000 | 0 | 0 | |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 59,999 | 460,790 | SH | SOLE | 460,790 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,372 | 140,680 | SH | SOLE | 140,680 | 0 | 0 | ||
JOHNSON & JOHNSON | COM | 478160104 | 1,176 | 7,280 | SH | SOLE | 7,280 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 4,812 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 51,644 | 652,150 | SH | SOLE | 652,150 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | *W EXP 99/99/999 | 54319Q113 | 551 | 427,178 | SH | SOLE | 427,178 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | COM CL A | 54319Q105 | 21,124 | 2,135,900 | SH | SOLE | 2,135,900 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 12,270 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 88,220 | 442,470 | SH | SOLE | 442,470 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 59 | 82,663 | SH | SOLE | 82,663 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 7,254 | 744,000 | SH | SOLE | 744,000 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 76,774 | 612,480 | SH | SOLE | 612,480 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 1,560 | 70,898 | SH | SOLE | 70,898 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 1,750 | 9,890 | SH | SOLE | 9,890 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 100,034 | 897,646 | SH | SOLE | 897,646 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 42,751 | 445,739 | SH | SOLE | 445,739 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 61,592 | 529,230 | SH | SOLE | 529,230 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 2,638 | 271,032 | SH | SOLE | 271,032 | 0 | 0 | ||
ORION ACQUISITION CORP | *W EXP 02/19/202 | 68626A116 | 88 | 137,305 | SH | SOLE | 137,305 | 0 | 0 | ||
ORION ACQUISITION CORP | COM CL A | 68626A108 | 5,310 | 547,385 | SH | SOLE | 547,385 | 0 | 0 | ||
PETCO HEALTH & WELLNESS CO I | COM | 71601V105 | 104,328 | 4,944,450 | SH | SOLE | 4,944,450 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 1,427 | 37,400 | SH | SOLE | 37,400 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 5,735 | 184,700 | SH | SOLE | 184,700 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 13,049 | 1,324,800 | SH | SOLE | 1,324,800 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 2,271 | 81,500 | SH | SOLE | 81,500 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 2,622 | 262,150 | SH | SOLE | 262,150 | 0 | 0 | ||
STRYKER CORPORATION | COM | 863667101 | 58,680 | 222,510 | SH | SOLE | 222,510 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 23,212 | 1,214,670 | SH | SOLE | 1,214,670 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 72,037 | 1,084,240 | SH | SOLE | 1,084,240 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 48,247 | 348,680 | SH | SOLE | 348,680 | 0 | 0 | ||
VENTAS INC | COM | 92276F100 | 40,028 | 725,010 | SH | SOLE | 725,010 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 2,306 | 49,640 | SH | SOLE | 49,640 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 23,633 | 130,290 | SH | SOLE | 130,290 | 0 | 0 | ||
WELLTOWER INC | COM | 95040Q104 | 50,880 | 617,480 | SH | SOLE | 617,480 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 48,385 | 330,590 | SH | SOLE | 330,590 | 0 | 0 | ||
ZOETIS INC | CL A | 98978V103 | 16,125 | 83,060 | SH | SOLE | 83,060 | 0 | 0 |